Literature DB >> 22859348

Natural killer cell cytolytic function in Korean patients with adult-onset Still's disease.

Jeong Ha Park1, Hee-Sun Kim, Jin Sook Lee, Jin Ju Kim, Kyong-Hee Jung, Yong-Wook Park, Dae-Hyun Yoo.   

Abstract

OBJECTIVE: To investigate natural killer (NK) cell proportions, NK cell cytotoxicity, and interleukin 18 (IL-18) expression, in patients with adult-onset Still's disease (AOSD).
METHODS: Forty-five patients with AOSD (active = 22, inactive = 23) and 32 healthy controls were included. The proportions of NK cells among peripheral blood mononuclear cells were assessed by flow cytometry. IL-18 and IL-18-binding protein (IL-18BP) concentrations were measured by ELISA. Twenty-four patients with AOSD and 18 controls were examined for cytotoxic activity of NK cells by co-incubating NK cells with NK-sensitive K562 cells. The association of NK cell function with clinical and laboratory measures was investigated.
RESULTS: The proportions of NK cells were significantly lower in patients with active AOSD than in patients with inactive disease and controls. NK cell cytotoxic function was significantly lower in patients with AOSD than in controls. NK cell proportions and cytotoxic functions were reexamined in 11 and 6 patients, respectively, after treatment. Low NK cell proportion and cytotoxic dysfunction were improved with clinical improvements of the patients. IL-18 and IL-18BP levels were much higher in patients with active AOSD than in controls. NK cell cytotoxic functions were consistently low and IL-18 and IL-18BP levels were constantly high in patients with AOSD, regardless of disease activity.
CONCLUSION: Low NK cell proportion, defective cytotoxic function, and elevated IL-18 levels may be significant features of AOSD. After resolution of the acute phase, low NK cell proportion was recovered and NK cell cytolytic function was restored along with clinical improvement. These findings possibly contribute to immunologic abnormalities in AOSD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22859348     DOI: 10.3899/jrheum.111500

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

Review 1.  Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.

Authors:  Yvan Jamilloux; Mathieu Gerfaud-Valentin; Fabio Martinon; Alexandre Belot; Thomas Henry; Pascal Sève
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  Upregulation of circulating microRNA-134 in adult-onset Still's disease and its use as potential biomarker.

Authors:  Tsai-Ling Liao; Yi-Ming Chen; Chia-Wei Hsieh; Hsin-Hua Chen; Hsiu-Chin Lee; Wei-Ting Hung; Kuo-Tung Tang; Der-Yuan Chen
Journal:  Sci Rep       Date:  2017-06-23       Impact factor: 4.379

Review 3.  Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review.

Authors:  Meng-Yan Wang; Jin-Chao Jia; Cheng-De Yang; Qiong-Yi Hu
Journal:  Chin Med J (Engl)       Date:  2019-12-05       Impact factor: 2.628

Review 4.  Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.

Authors:  Jessica Vandenhaute; Carine H Wouters; Patrick Matthys
Journal:  Front Immunol       Date:  2020-01-15       Impact factor: 7.561

5.  Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.

Authors:  Zhihong Wang; Huihui Chi; Yue Sun; Jialin Teng; Tienan Feng; Honglei Liu; Xiaobing Cheng; Junna Ye; Hui Shi; Qiongyi Hu; Jinchao Jia; Tingting Liu; Liyan Wan; Zhuochao Zhou; Xin Qiao; Chengde Yang; Yutong Su
Journal:  Rheumatology (Oxford)       Date:  2020-11-01       Impact factor: 7.580

Review 6.  Interleukin-18 Binding Protein in Immune Regulation and Autoimmune Diseases.

Authors:  Seung Yong Park; Yasmin Hisham; Hyun Mu Shin; Su Cheong Yeom; Soohyun Kim
Journal:  Biomedicines       Date:  2022-07-20

Review 7.  Adult-onset Still's disease: A disease at the crossroad of innate immunity and autoimmunity.

Authors:  Shijia Rao; Lemuel Shui-Lun Tsang; Ming Zhao; Wei Shi; Qianjin Lu
Journal:  Front Med (Lausanne)       Date:  2022-08-22

Review 8.  Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review.

Authors:  Jasper F Nies; Udo Schneider; Martin Krusche
Journal:  Front Med (Lausanne)       Date:  2022-09-16

Review 9.  Interleukin-18: Biological properties and role in disease pathogenesis.

Authors:  Gilles Kaplanski
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

Review 10.  The Role of Interleukin 18/Interleukin 18-Binding Protein in Adult-Onset Still's Disease and Systemic Juvenile Idiopathic Arthritis.

Authors:  Charlotte Girard-Guyonvarc'h; Mathilde Harel; Cem Gabay
Journal:  J Clin Med       Date:  2022-01-15       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.